Bajaj Healthcare Ltd

Bajaj Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Bajaj Healthcare Ltd

₹ 391 1.48%
22 Nov 4:00 p.m.
bajajhealth.com BSE: 539872 NSE: BAJAJHCARE
About

Incorporated in 1993, Bajaj Healthcare Ltd manufactures a wide range of Active Pharmaceutical Ingredients and Formulations[1]

Key Points

Business Overview:[1][2][3]
BHL is focused on development, supply, manufacturing of Amino Acids, Nutritional Supplements and Active Pharma Ingredients for Pharmaceutical, Nutraceuticals and Food industries. It manufactures active pharmaceutical ingredients and formulations in the form of tablets, capsules, powder, etc. for ~550+ clients, exporting bulk drugs to ~62+ countries in Europe, USA, Africa, Australia, etc.

Website BSE NSE
  • Market Cap ₹ 1,076 Cr.
  • Current Price ₹ 391
  • High / Low ₹ 428 / 263
  • Stock P/E 31.5
  • Book Value ₹ 162
  • Dividend Yield 0.26 %
  • ROCE 8.23 %
  • ROE -12.2 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has reduced debt.

Cons

  • Promoter holding has decreased over last quarter: -8.54%
  • The company has delivered a poor sales growth of 5.04% over past five years.
  • Company has a low return on equity of 7.77% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
167.57 175.71 163.79 195.32 132.57 154.11 129.74 101.21 108.57 133.90 132.25 133.09
136.75 150.50 139.33 160.89 102.13 132.08 108.00 82.27 89.04 117.87 107.75 108.56
Operating Profit 30.82 25.21 24.46 34.43 30.44 22.03 21.74 18.94 19.53 16.03 24.50 24.53
OPM % 18.39% 14.35% 14.93% 17.63% 22.96% 14.29% 16.76% 18.71% 17.99% 11.97% 18.53% 18.43%
0.20 0.45 -1.66 -4.79 -5.63 -6.84 -55.02 -7.36 -6.92 -35.80 -0.04 3.73
Interest 2.84 4.49 2.58 3.64 5.37 5.97 8.75 8.26 6.65 6.01 8.44 7.88
Depreciation 4.86 4.24 4.08 4.00 4.43 4.69 6.31 6.66 7.35 7.30 6.73 6.81
Profit before tax 23.32 16.93 16.14 22.00 15.01 4.53 -48.34 -3.34 -1.39 -33.08 9.29 13.57
Tax % 25.21% -3.25% 25.53% 25.64% 26.38% 20.53% -0.25% 3.59% 57.55% -9.52% 23.25% 30.21%
17.45 17.47 12.02 16.36 11.05 3.59 -48.21 -3.46 -2.20 -29.92 7.13 9.46
EPS in Rs 6.32 6.33 4.36 5.93 4.00 1.30 -17.47 -1.25 -0.80 -10.84 2.58 3.43
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
171 205 218 223 231 327 370 410 657 680 646 473 508
158 186 189 193 200 288 327 362 521 561 534 397 423
Operating Profit 13 19 29 30 31 39 43 48 136 119 112 76 85
OPM % 7% 9% 13% 14% 13% 12% 12% 12% 21% 17% 17% 16% 17%
0 0 0 0 2 2 1 7 7 1 -19 -105 -39
Interest 6 7 8 8 8 8 8 7 8 13 18 30 29
Depreciation 8 9 9 9 11 11 11 12 16 18 17 28 28
Profit before tax -2 3 12 14 14 23 24 36 119 90 58 -86 -12
Tax % -31% 40% 37% 39% 43% 33% 33% 30% 30% 20% 25% -3%
-1 2 8 8 8 15 16 25 83 71 43 -84 -16
EPS in Rs -1.18 2.19 8.34 3.04 2.83 5.50 5.91 9.14 30.11 25.87 15.59 -30.36 -5.63
Dividend Payout % 0% 0% 0% 0% 0% 5% 0% 0% 5% 6% 6% -3%
Compounded Sales Growth
10 Years: 9%
5 Years: 5%
3 Years: -10%
TTM: -2%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -15%
Stock Price CAGR
10 Years: %
5 Years: 34%
3 Years: 6%
1 Year: 3%
Return on Equity
10 Years: 13%
5 Years: 14%
3 Years: 8%
Last Year: -12%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 2 2 2 7 7 7 7 14 14 14 14 14 16
Reserves 26 28 78 82 92 107 122 164 245 315 354 265 430
72 72 70 81 75 87 81 91 181 257 415 333 206
31 43 38 39 45 68 57 74 86 136 115 154 152
Total Liabilities 131 145 189 209 219 268 267 343 526 721 898 765 804
54 56 108 130 128 127 128 162 208 270 366 253 240
CWIP 5 3 1 1 0 2 1 5 57 52 22 7 10
Investments 0 0 0 0 0 0 0 5 0 0 0 0 0
72 87 79 78 91 140 137 170 260 399 510 506 554
Total Assets 131 145 189 209 219 268 267 343 526 721 898 765 804

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
14 17 28 25 22 17 25 21 44 1 -22 92
-8 -9 -17 -31 -8 -12 -13 -28 -109 -75 -93 -11
-7 -8 -11 5 -13 2 -13 3 75 62 131 -97
Net Cash Flow -0 1 -0 -0 0 7 -0 -4 10 -12 16 -16

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 95 98 86 70 83 90 77 88 55 99 110 139
Inventory Days 43 51 50 56 45 57 45 54 94 143 199 206
Days Payable 51 68 63 46 51 74 45 80 67 94 81 128
Cash Conversion Cycle 87 81 73 80 78 73 77 62 82 148 228 217
Working Capital Days 71 62 52 52 58 61 66 76 90 142 208 226
ROCE % 5% 10% 16% 13% 13% 16% 16% 18% 36% 20% 14% 8%

Shareholding Pattern

Numbers in percentages

2 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
67.26% 67.26% 67.30% 67.30% 67.42% 67.49% 67.49% 67.69% 67.73% 67.74% 67.74% 59.19%
0.32% 0.38% 0.32% 0.09% 0.94% 0.78% 0.69% 0.66% 0.74% 0.53% 0.00% 1.07%
0.00% 0.00% 0.00% 0.00% 0.34% 0.34% 0.34% 0.43% 0.48% 0.43% 0.00% 1.97%
32.42% 32.36% 32.38% 32.62% 31.30% 31.38% 31.48% 31.22% 31.06% 31.31% 32.27% 37.77%
No. of Shareholders 32,30930,72330,90929,76926,93026,03727,32228,00829,62632,71232,39731,995

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Jun 2022
    Transcript
    Notes
    PPT
  • Aug 2020
    Transcript
    Notes
    PPT